bioTheranostics

bioTheranostics

bioTheranostics

Biotheranostics discovers and develops proprietary molecularbased tests that provide physicians with actionable information to help guide cancer treatment..
Raised
$32M
Follow us
Alexa global traffic share
Team Size
10+
Employees
$32,000,000 Private equity
Xconomy

BioTheranostics, Acquired in 2008, To Go Independent in $32M Deal

Health Funding Strategy